Back to Search
ASHLEY TOLLEFSON, MD
MD
Anesthesiology Physician
NPI: 1891228508IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
MD61148883(WA)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
UNIVERSITY OF MINNESOTA MEDICAL SCHOOL
Class of 2017
Research & Publications (20)
An acute toxicology study with INGN 007, an oncolytic adenovirus vector, in mice and permissive Syrian hamsters; comparisons with wild-type Ad5 and a replication-defective adenovirus vector.
PMID 19197324·Cancer Gene Ther·2009
4-observational
INGN 007, an oncolytic adenovirus vector, replicates in Syrian hamsters but not mice: comparison of biodistribution studies.
PMID 19197322·Cancer Gene Ther·2009
4-observational
Identification of a new human adenovirus protein encoded by a novel late l-strand transcription unit.
PMID 17881437·J Virol·2007
8-other
Preparation and titration of CsCl-banded adenovirus stocks.
PMID 17401177·Methods Mol Med·2007
8-other
Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors.
PMID 16452178·Cancer Res·2006
7-preclinical
Ceramide regulates SR protein phosphorylation during adenoviral infection.
PMID 16271740·Virology·2006
8-other
Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression.
PMID 16034456·Gene Ther·2005
7-preclinical
Cotton rat tumor model for the evaluation of oncolytic adenoviruses.
PMID 15703497·Hum Gene Ther·2005
7-preclinical
Adenovirus immunoregulatory E3 proteins prolong transplants of human cells in immunocompetent mice.
PMID 15681065·Virus Res·2005
7-preclinical
Adenovirus E3-6.7K protein is required in conjunction with the E3-RID protein complex for the internalization and degradation of TRAIL receptor 2.
PMID 15507617·J Virol·2004
8-other
An oncolytic adenovirus vector combining enhanced cell-to-cell spreading, mediated by the ADP cytolytic protein, with selective replication in cancer cells with deregulated wnt signaling.
PMID 15150123·Cancer Res·2004
7-preclinical
Distinct domains in the adenovirus E3 RIDalpha protein are required for degradation of Fas and the epidermal growth factor receptor.
PMID 14557654·J Virol·2003
8-other
Mutations within the ADP (E3-11.6K) protein alter processing and localization of ADP and the kinetics of cell lysis of adenovirus-infected cells.
PMID 12829816·J Virol·2003
7-preclinical
Overexpression of the ADP (E3-11.6K) protein increases cell lysis and spread of adenovirus.
PMID 12573583·Virology·2003
8-other
Adenovirus RIDbeta subunit contains a tyrosine residue that is critical for RID-mediated receptor internalization and inhibition of Fas- and TRAIL-induced apoptosis.
PMID 12388693·J Virol·2002
7-preclinical
Construction and characterization of E1-minus replication-defective adenovirus vectors that express E3 proteins from the E1 region.
PMID 12359450·Virology·2002
8-other
Upregulation of the Golgi protein GP73 by adenovirus infection requires the E1A CtBP interaction domain.
PMID 12359426·Virology·2002
8-other
Adenovirus replication-competent vectors (KD1, KD3) complement the cytotoxicity and transgene expression from replication-defective vectors (Ad-GFP, Ad-Luc).
PMID 12136425·Cancer Gene Ther·2002
7-preclinical
Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins.
PMID 11533151·J Virol·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 12040 NE 128TH ST
KIRKLAND, WA 98034 - Phone
- (425) 899-3455
Quick Facts
- NPI
- 1891228508
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 9
- Publications
- 20
Are you this provider?
Claim Your Profile